Visit GW SMHS ON CAMPUS Policies and Guidelines website
More than 150 MD program students presented abstracts, poster sessions, and selected oral presentations on a range of disciplines, such as clinical and translational science, clinical public health, and medical education-related research.
The GW School of Medicine and Health Sciences has been selected to serve as one of 24 participating sites for the Phase 2 clinical trial to evaluate additional COVID-19 booster shots in adults, including multiple vaccines based on viral variants such as Delta and Omicron. The trial aims to understand if different vaccine regimens – prototype and variant vaccines alone and in combinations – can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.
WASHINGTON (March 24, 2022) - Researchers at the George Washington University published findings